Cognition Therapeutics, Inc. Lease, Cost
Cognition Therapeutics, Inc. (CGTX) reported Lease, Cost of $50.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2022-11-14
- Cognition Therapeutics, Inc. lease, cost for the quarter ending 2022-09-30 was $50.00K.
- Cognition Therapeutics, Inc. lease, cost for the quarter ending 2022-06-30 was $49.00K.
- Cognition Therapeutics, Inc. lease, cost for the quarter ending 2022-03-31 was $50.00K.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month |
|---|---|---|---|
| 2022-09-30 | $50.00K 10-Q · filed 2022-11-14 | $99.00K derived: sum of 2 quarters · filed 2022-11-14 | $149.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $49.00K 10-Q · filed 2022-08-09 | $99.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $50.00K 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |